open access

Vol 9, No 6 (2008): Practical Diabetology
Review articles (submitted)
Published online: 2008-12-22
Get Citation

Drug-induced hypoglycemia in type 2 diabetic patients

Roman Kuczerowski
Diabetologia Praktyczna 2008;9(6):277-284.

open access

Vol 9, No 6 (2008): Practical Diabetology
Review articles (submitted)
Published online: 2008-12-22

Abstract

Drug-induced hypoglycemia is one of the most relevant limiting factors in obtaining good metabolic control necessary to prevent angiopathy in diabetic patients. Mortality associated with insulin therapy is estimated as 2-4%. Hypoglycemic coma is a life-threatening state. Prolonged hypoglycemia may cause irreversible neurological deficiencies. Hypoglycemia may induce cardiac ischemia and arrhythmias. The risk factors of severe hypoglycemia include intensive insulin therapy, old age, autonomic neuropathy, impair secretion of counterregulatory hormones, renal failure, liver injury and previous episode of severe hypoglycemia. Hypoglycemia may be side effect of treatment with insulin, sulfonylureas, glinides, DPP-4 inhibitors. Metformin in monotherapy does not cause hypoglycemia. Combined therapy (insulin and metformin) may reduce the risk of hypoglycemia. Education of patients and their families, availability of self-control, appropriate management of type 2 diabetes makes possible to obtain good metabolic control without severe hypoglycemia.

Abstract

Drug-induced hypoglycemia is one of the most relevant limiting factors in obtaining good metabolic control necessary to prevent angiopathy in diabetic patients. Mortality associated with insulin therapy is estimated as 2-4%. Hypoglycemic coma is a life-threatening state. Prolonged hypoglycemia may cause irreversible neurological deficiencies. Hypoglycemia may induce cardiac ischemia and arrhythmias. The risk factors of severe hypoglycemia include intensive insulin therapy, old age, autonomic neuropathy, impair secretion of counterregulatory hormones, renal failure, liver injury and previous episode of severe hypoglycemia. Hypoglycemia may be side effect of treatment with insulin, sulfonylureas, glinides, DPP-4 inhibitors. Metformin in monotherapy does not cause hypoglycemia. Combined therapy (insulin and metformin) may reduce the risk of hypoglycemia. Education of patients and their families, availability of self-control, appropriate management of type 2 diabetes makes possible to obtain good metabolic control without severe hypoglycemia.
Get Citation

Keywords

hypoglycemia; type 2 diabetes; pharmacotherapy

About this article
Title

Drug-induced hypoglycemia in type 2 diabetic patients

Journal

Clinical Diabetology

Issue

Vol 9, No 6 (2008): Practical Diabetology

Pages

277-284

Published online

2008-12-22

Bibliographic record

Diabetologia Praktyczna 2008;9(6):277-284.

Keywords

hypoglycemia
type 2 diabetes
pharmacotherapy

Authors

Roman Kuczerowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl